Article Type
Review
Published
This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.
Review
This article provides a narrative review on the current non-glycaemic and glycaemic treatment options for cardiovascular risk reduction in patients with Type 2 diabetes and atherosclerotic cardiovascular disease.
Review
This narrative review provides the most up-to-date information regarding existing and new pharmacotherapy for the management of chronic kidney disease amongst people with diabetes, specifically type 2 diabetes.
Editorial
The Senior Editors of Drugs in Context provide us with their expert opinion on the events of 2020 and what lies ahead in 2021.
Review
This article reviews the recommendations of different diabetes organizations for achieving glycemic control.
Review
This review discusses the efficacy and safety of semaglutide, which have
been investigated in an extensive clinical development
program including more than 9,000 patients with type 2
diabetes.